Riskpilot← Back to searchSign inGet full accessAvidicare AB
ABActiveOrg 5568239585Scheelevägen 2Manufacture of medical and dental instruments and supplies · NACE 3250Est. 20107 employees
Revenue 2024
SEK 14,8M
-44% vs 2023
EBITDA margin
-100.1%
-113% vs 2023
Equity ratio
6.0%
Financial strength
Net profit 2024
SEK -16,1M
-97% vs 2023
| Revenue | SEK 14,8M | -44% |
| EBITDA | SEK -14,8M | -113% |
| Net profit | SEK -16,1M | -97% |
| Total assets | SEK 8M | -31% |
| Equity | SEK 482K | -92% |
| Employees | 7 | — |
Legal name
Avidicare AB
Org number
5568239585
Legal form
Aktiebolag
NACE code
3250 · Manufacture of medical and dental instruments and supplies
Founded
4 november 2010
Share capital
SEK 50 000
Employees
7 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av Jendi, Jonas i förening med en av Höjerback, Johan Peter von Schenck, Erik Carl Bernhard Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva utveckling och tillverkning av samt handel inom medicinsk luftbehandling samt därmed förenlig verksamhet.
Address
Scheelevägen 2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | 11 253 | 13 739 | 7 360 | 8 302 | 15 632 | 26 198 | 14 788 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | −2 723 | −4 019 | −13 662 | −8 028 | −7 089 | −13 753 | −15 399 | −15 559 | −6 953 | −14 808 |
| Depreciation & amort. | −1 668 | −1 440 | −1 352 | −1 051 | −3 424 | −1 018 | −1 113 | −882 | −1 255 | −1 336 |
| EBIT | −4 391 | −5 459 | −15 014 | −9 079 | −10 513 | −14 771 | −16 512 | −16 441 | −8 208 | −16 144 |
| Net financials | −141 | −62 | −5 | −1 | −2 | −1 | −3 | −8 | −1 | — |
| Profit before tax | −4 531 | −5 521 | −15 019 | −9 081 | −10 515 | −14 772 | −16 514 | −16 448 | −8 210 | −16 145 |
| Tax | 147 | 144 | 144 | 171 | 140 | 135 | 135 | 67 | −0 | −0 |
| Net profit | −4 384 | −5 377 | −14 875 | −8 910 | −10 375 | −14 637 | −16 379 | −16 381 | −8 210 | −16 145 |
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 18 315 | 21 286 | 10 816 | 16 188 | 9 829 | 9 544 | 9 987 | 12 386 | 11 670 | 8 045 |
| Equity | 13 530 | 18 152 | 3 277 | 4 367 | 992 | 355 | 976 | 5 094 | 5 885 | 482 |
| Long-term debt | 258 | 258 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 3 591 | 2 084 | 6 891 | 11 344 | 8 500 | 8 987 | 8 944 | 8 944 | 5 785 | 7 563 |
| Total debt | 3 849 | 2 342 | 6 891 | 11 344 | 8 500 | 8 987 | 8 944 | 8 944 | 5 785 | 7 563 |
EBITDA margin
-100.1%
This company
15.8%
Market median
-734% vs market
20152024
Equity ratio
6.0%
This company
38.2%
Market median
-84% vs market
20152024
Return on equity
-3349.6%
This company
18.4%
Market median
-18304% vs market
20152024
Net profit margin
-109.2%
This company
8.1%
Market median
-1448% vs market
20152024
Asset turnover
1.84×
This company
1.12×
Market median
+64% vs market
20152024
Debt / equity
15.69×
This company
0.62×
Market median
-2431% vs market
20152024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Bolagsverket / SCB · Period 2015-01-01 – 2015-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
JP Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
LÅ Chief Auditor | Chief Auditor | 2020 | — | — |
AE Chief Auditor | Chief Auditor | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Chairman | 2020 | — | — | |
| Board of Directors | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Avidicare Holding AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Avidicare Holding AB
Avidicare AB Board members of Avidicare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Peter Höjerback | Chief Executive Officer | 0 companies |
| Lars Åke Anders Hjalmarsson | Chief Auditor | 0 companies |
| Anna Elsa Karoline Tedevall | Chief Auditor | 0 companies |
| Jonas Jendi | Board of Directors | 0 companies |
| Erik Carl Bernhard von Schenck | Chairman | 0 companies |
| Ulf Åke Lewander | Board of Directors | 0 companies |